Abstract | OBJECTIVE: METHODS: The study group comprised 21 JIA patients being treated with IA methylprednisolone [MP (n = 15) or MP plus triamcinolone hexacetonide (THA) (n = 6)] prescribed on clinical indications. The systemic effect of MP was assessed by measuring circulating glucocorticoid bioactivity (GBA) with a recombinant cell transactivation assay 7 and 24 h after the IA injections, and after 2 months. The systemic immunological responses were studied with a novel assay for testing patient serum-induced changes in the secretion of interferon (IFN)-γ and interleukin (IL)-5 from target cells. RESULTS: Administration of IA GC induced serum GBA (p = 0.001) and suppressed circulating cortisol levels (p = 0.002) 7 h after the injection. Serum withdrawn 24 h after the IA injection induced less IL-5 secretion from mitogen-activated target cells when compared with pre-treatment sera (p = 0.036). This decrease in target cell T helper (Th)2 response (IL-5) was MP dose related (r = -0.550, p = 0.018). High IL-5 secretion from target cells prior to the IA injections was associated with good clinical outcome at 2 months, seen as a low number of active (p = 0.044) and restricted joints (p = 0.049). CONCLUSION: IA GC injections have systemic effects that are reflected in the serum as an immediate elevation of GBA, a decrease of endogenous cortisol as well as a suppressive effect of patient serum on target cell IL-5 secretion. These systemic effects may play a role in the attenuation of disease activity.
|
Authors | H Rintamäki, K Tamm, O Vaarala, M Sidoroff, V Honkanen, T Raivio, Oa Jänne, K-L Kolho |
Journal | Scandinavian journal of rheumatology
(Scand J Rheumatol)
Vol. 40
Issue 5
Pg. 347-53
( 2011)
ISSN: 1502-7732 [Electronic] England |
PMID | 21619491
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Glucocorticoids
- Interleukin-5
- Interferon-gamma
- Triamcinolone Acetonide
- triamcinolone hexacetonide
- Hydrocortisone
- Methylprednisolone
|
Topics |
- Adolescent
- Anti-Inflammatory Agents
(administration & dosage)
- Arthritis, Juvenile
(drug therapy, immunology)
- Child
- Female
- Glucocorticoids
(administration & dosage, blood)
- Humans
- Hydrocortisone
(blood)
- Immune System
(drug effects)
- Injections, Intra-Articular
- Interferon-gamma
(blood, metabolism)
- Interleukin-5
(blood, metabolism)
- Male
- Methylprednisolone
(administration & dosage, immunology)
- Prospective Studies
- Th2 Cells
(drug effects)
- Treatment Outcome
- Triamcinolone Acetonide
(administration & dosage, analogs & derivatives)
|